NewsAmgen "neutral," target price raised
31.07.08 - UBS
NEW YORK, July 31 (newratings.com) - Analysts at UBS reiterate their "neutral" rating on Amgen Inc (AMGN). The target price has been raised from $47 to $68.
Share Empfehlen Sie diesen Artikel einem Freund!
AMGN zu meinen Aktien hinzufügen und E-Mail Alerts auf Amgen abonnieren